Rx Pak Division of McKesson Corporation
Rx Pak Division of McKesson Corporation appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1007-2019, Class II) was initiated on January 16, 2019.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1007-2019 | Class II | Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use | January 16, 2019 |